Comprehensive Biomarker Discovery Platform Reveals Qualified MRM Assay for Prediction of INF/Ribavirin Treatment Response in Hepatitis C Patients

The current standard of care for chronic Hepatitis C (CHC) results in sustained viral response in only half of patients and also has significant side effects. Improved pre-treatment clinical predictors of response are needed to individualize treatment and select individuals most appropriate for new...

Full description

Saved in:
Bibliographic Details
Main Authors: Dubois, L.G., Patel, K., Lucas, J.E., McCarthy, J., McHutchison, J.G., Moseley, M.A., Thompson, J.W.
Format: Artigo
Language:Inglês
Published: Association of Biomolecular Resource Facilities 2011
Subjects:
Poster Session Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186590/
Tags: Add Tag
No Tags, Be the first to tag this record!
Loading...

Similar Items